Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

83
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
83
Symbiosis00:58

Symbiosis

38.8K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
38.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Explainable Artificial Intelligence (xAI) for 5-HT<sub>2A</sub> Receptor Binding Affinity of New Psychoactive Substances.

Molecules (Basel, Switzerland)·2026
Same author

Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligence.

Frontiers in pharmacology·2026
Same author

ASP-COMPLEX: redefining antimicrobial stewardship to improve outcomes in high-risk patients with severe infections.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2026
Same author

Polymicrobial Infection Is Associated with Failure of DAIR in Acute Hip Periprosthetic Joint Infection.

Surgical infections·2026
Same author

Ivermectin to Control Malaria - A Cluster-Randomized Trial. Reply.

The New England journal of medicine·2026
Same author

Improving Population Pharmacokinetic Modelling with Artificial Patients using Generative Artificial Intelligence.

Pharmacology research & perspectives·2026
Same journal

Genotypic analysis of Plasmodium falciparum malaria parasites in a clinical trial of RTS,S vaccination in combination with seasonal malaria chemoprevention.

Malaria journal·2026
Same journal

Less is more: modelling the impact of species-targeted versus broadcast larviciding in Anopheles funestus-dominated malaria transmission settings.

Malaria journal·2026
Same journal

'Poverty is the biggest barrier': stakeholder perspectives on social determinants of malaria in Wakiso District, Uganda.

Malaria journal·2026
Same journal

Clinical malaria recurrence and associated factors in infancy following IPTp-DP versus IPTp-SP in Busia, Uganda; a secondary analysis using the Conditional Frailty model.

Malaria journal·2026
Same journal

Prevalence of molecular markers related to artemisinin partial resistance and ACT partner drug resistance in the Plasmodium falciparum population in Kongo Central, DRC.

Malaria journal·2026
Same journal

Malaria among febrile patients during a yellow fever outbreak in Ghana: a cross-sectional study.

Malaria journal·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.9K

Screening for an ivermectin slow-release formulation suitable for malaria vector control.

Carlos Chaccour, Ángel Barrio, Ana Gloria Gil Royo

    Malaria Journal
    |April 16, 2015
    PubMed
    Summary
    This summary is machine-generated.

    New slow-release ivermectin formulations show promise for malaria vector control. Subcutaneous implants safely maintained mosquito-killing ivermectin levels in rabbits for up to six months, potentially reducing vector density significantly.

    More Related Videos

    Generating Genetically Modified Plasmodium berghei Sporozoites
    10:16

    Generating Genetically Modified Plasmodium berghei Sporozoites

    Published on: May 5, 2023

    1.9K
    Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
    07:14

    Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

    Published on: July 11, 2025

    634

    Related Experiment Videos

    Last Updated: Apr 14, 2026

    Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
    05:28

    Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

    Published on: May 12, 2022

    3.9K
    Generating Genetically Modified Plasmodium berghei Sporozoites
    10:16

    Generating Genetically Modified Plasmodium berghei Sporozoites

    Published on: May 5, 2023

    1.9K
    Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
    07:14

    Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

    Published on: July 11, 2025

    634

    Area of Science:

    • Pharmacology
    • Vector Biology
    • Malaria Control

    Background:

    • Malaria elimination faces challenges from insecticide resistance and outdoor-biting mosquitoes.
    • Ivermectin offers a dual approach by targeting mosquitoes feeding on treated hosts.
    • Current oral ivermectin doses provide only transient mosquitocidal effects.

    Purpose of the Study:

    • To develop and evaluate novel slow-release ivermectin formulations for sustained mosquitocidal activity.
    • To assess the safety and efficacy of these formulations in a preclinical model.

    Main Methods:

    • Screened three slow-release ivermectin formulations in silicone implants in rabbits.
    • Monitored animal toxicity and quantified ivermectin plasma levels over time.
    • Utilized mathematical modeling to predict the impact on vector populations.

    Main Results:

    • All tested formulations released ivermectin for over 12 weeks.
    • Four formulations maintained lethal ivermectin levels against Anopheles gambiae for up to 24 weeks.
    • No significant adverse effects were observed; modeling predicted a 98% reduction in vector density with a 12-week formulation.

    Conclusions:

    • Subcutaneous ivermectin implants can safely achieve prolonged mosquitocidal plasma concentrations.
    • This novel formulation strategy holds potential for effective malaria vector control.
    • Further development of ivermectin formulations could overcome current limitations in malaria elimination efforts.